Jeong Jae Hwan, Kang Chang Moo
Department of Hepatobiliary and Pancreatic Surgery, Yonsei University College of Medicine, Seoul, Korea.
J Minim Invasive Surg. 2024 Dec 15;27(4):227-231. doi: 10.7602/jmis.2024.27.4.227.
Central pancreatectomy (CP) is a viable option for low malignant tumors located in the neck or proximal body of the pancreas. This procedure has the advantage of minimizing impairment to pancreatic function. However, it is technically challenging and carries a relatively high risk of postoperative pancreatic fistula. Recently, minimally invasive CP surgery has gained popularity, with evidence supporting its safety and efficacy. Nevertheless, conventional laparoscopic CP presents technical difficulties, while robot-assisted CP is associated with higher costs. ArtiSential (LivsMed Inc.) is a device that has been successfully utilized in various surgical procedures, offering the ergonomic advantages of robotic surgery within a laparoscopic setting. In this article, we share our successful experience of performing laparoscopic CP using ArtiSential in a patient with intraductal papillary mucinous neoplasm.
中央型胰腺切除术（CP）是位于胰腺颈部或胰体近端的低恶性肿瘤的一种可行选择。该手术具有将胰腺功能损害降至最低的优点。然而，它在技术上具有挑战性，并且术后胰瘘风险相对较高。最近，微创CP手术越来越受欢迎，有证据支持其安全性和有效性。尽管如此，传统的腹腔镜CP存在技术困难，而机器人辅助CP则成本更高。ArtiSential（LivsMed公司）是一种已成功应用于各种外科手术的设备，在腹腔镜环境中提供了机器人手术的人体工程学优势。在本文中，我们分享了在一名导管内乳头状黏液性肿瘤患者中使用ArtiSential进行腹腔镜CP的成功经验。
